JUSTIN LEE: Open Payments
NPI 1528523057 · NORTHBROOK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,618 in 86 payments from 15 companies in 2025. Trend: 2023 $1,495 · 2024 $2,028 · 2025 $1,618
Food & beverage: $1,618
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $414 |
| Neurocrine BioSciences, Inc. | 6 | $180 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $172 |
| Collegium Pharmaceutical, Inc. | 8 | $161 |
| Otsuka America Pharmaceutical, Inc. | 5 | $115 |
| Lundbeck LLC | 5 | $93 |
| Axsome Therapeutics, Inc. | 4 | $91 |
| Neos Therapeutics, LP | 5 | $89 |
| Janssen Pharmaceuticals, Inc | 3 | $72 |
| Alkermes, Inc. | 2 | $64 |
Products named: VRAYLAR, REXULTI, INGREZZA, CAPLYTA, Jornay PM, Auvelity, Adzenys XR-ODT, ARISTADA.
Industry payments across IL — which companies pay providers there.
